Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy

This study evaluated the efficacy and safety of adding etanercept to disease-modifying antirheumatic drugs (DMARDs) in patients with moderately active rheumatoid arthritis (RA). This randomized, double-blind, placebo-controlled study (ClinicalTrials.gov #NCT01313208) enrolled RA patients with Diseas...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Springerplus
Hlavní autoři: Hobbs, Kathryn, Deodhar, Atul, Wang, Brian, Bitman, Bojena, Nussbaum, Joyce, Chung, James, Collier, David H
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer International Publishing 2015
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4359699/
https://ncbi.nlm.nih.gov/pubmed/25793152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-015-0895-9
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky